Cypress Capital Management (Wyoming)’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.73M Buy
44,860
+7,000
+18% +$289K 1.6% 21
2025
Q4
$1.56M Hold
37,860
1.45% 23
2025
Q3
$1.41M Sell
37,860
-685
-2% -$24.9K 1.3% 24
2025
Q2
$1.41M Buy
+38,545
New +$1.4M 1.53% 21

Other funds holding BME

Cypress Capital Management (Wyoming)'s BME Position: Q1 2026 in Review

Cypress Capital Management (Wyoming) increased its BlackRock Health Sciences Trust (BME) stake by 18% in Q1 2026, buying an estimated $289K and bringing the position to 44,860 shares worth $1.73M. The position accounts for 1.6% of the portfolio, ranked #21.

Cypress Capital Management (Wyoming) first reported a position in BME in Q2 2025 and has held it in 4 quarters since. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.

  • Cypress Capital Management (Wyoming) held 44,860 shares of BlackRock Health Sciences Trust worth $1.73M as of Q1 2026.
  • Cypress Capital Management (Wyoming) bought 7,000 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $289K.
  • BlackRock Health Sciences Trust made up 1.6% of Cypress Capital Management (Wyoming)'s portfolio in Q1 2026, its #21 holding.
  • Cypress Capital Management (Wyoming) first reported a position in BlackRock Health Sciences Trust in Q2 2025 and has held it in 4 quarters since.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q1 2026, filed 8 May 2026.